Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results…
<!-- Name:DistributionId Value:8840010 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Bioventus
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial…
DURHAM, N.C., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today amended its…
Global Joint Pain Injections Market is Expected to Generate $13.2 Billion by 2031:…
Portland, OR, Nov. 15, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Joint Pain Injections Market size garnered $6.3 billion…
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago…
DURHAM, N.C., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present its spine…
Bioventus to buy CartiHeal despite financing problems
US orthologics company Bioventus will acquire Israeli cartilage treatment company CartiHeal, despite its problems in financing the deal.
Last month, Bioventus…
Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives
DURHAM, N.C., April 08, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that…
Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer,…
Bioventus Receives US FDA Clearance for BoneScalpel® Access™
DURHAM, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the US Food and…